DK406389D0 - Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK406389D0
DK406389D0 DK406389A DK406389A DK406389D0 DK 406389 D0 DK406389 D0 DK 406389D0 DK 406389 A DK406389 A DK 406389A DK 406389 A DK406389 A DK 406389A DK 406389 D0 DK406389 D0 DK 406389D0
Authority
DK
Denmark
Prior art keywords
thiazolo
connection
pharmaceutical preparation
preparation containing
pyrimidine compound
Prior art date
Application number
DK406389A
Other languages
English (en)
Other versions
DK406389A (da
Inventor
Roland Kenith Robins
Howard Brinkerhoff Cottam
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/136,020 external-priority patent/US4880784A/en
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Publication of DK406389D0 publication Critical patent/DK406389D0/da
Publication of DK406389A publication Critical patent/DK406389A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK406389A 1987-12-21 1989-08-18 Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse DK406389A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/136,020 US4880784A (en) 1987-12-21 1987-12-21 Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US07/236,366 US5041426A (en) 1987-12-21 1988-08-25 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
PCT/US1988/002982 WO1989005649A1 (en) 1987-12-21 1988-09-02 Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides

Publications (2)

Publication Number Publication Date
DK406389D0 true DK406389D0 (da) 1989-08-18
DK406389A DK406389A (da) 1989-10-04

Family

ID=26833912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK406389A DK406389A (da) 1987-12-21 1989-08-18 Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse

Country Status (11)

Country Link
US (1) US5041426A (da)
EP (2) EP0636372B1 (da)
JP (1) JP2590248B2 (da)
KR (1) KR970002611B1 (da)
AR (1) AR246104A1 (da)
AT (2) ATE173929T1 (da)
CA (1) CA1319931C (da)
DE (2) DE3856279T2 (da)
DK (1) DK406389A (da)
ES (1) ES2010786A6 (da)
WO (1) WO1989005649A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
CA1335572C (en) * 1988-05-23 1995-05-16 Yoon Sang Cho-Chung Derivatives of cyclic amp as treatment for cancer
IL129126A0 (en) * 1996-10-16 2000-02-17 Icn Pharmaceuticals Monocyclic l-nucleosides analogs and uses thereof
US6509320B1 (en) * 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
ATE271063T1 (de) * 1996-10-16 2004-07-15 Icn Pharmaceuticals Purin-l-nukleoside, deren analoga und verwendungen
EP1103559A1 (en) * 1997-01-17 2001-05-30 ICN Pharmaceuticals, Inc. Autoimmune nucleosides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US6645990B2 (en) * 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
EA008380B1 (ru) * 2001-11-27 2007-04-27 Анадис Фармасьютикалз, Инк. 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
CN1845745B (zh) * 2003-09-05 2011-11-02 安那迪斯药品股份有限公司 Tlr7配体及其前药在制备用于治疗丙型肝炎病毒感染的药物中的用途
EP1667694B1 (en) * 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
US20080070852A1 (en) * 2004-06-07 2008-03-20 Averett Devron R 3-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses Thereof
CN101212968B (zh) * 2004-12-17 2011-11-16 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
CN102504001B (zh) * 2004-12-17 2015-02-25 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
SG152296A1 (en) 2005-11-21 2009-05-29 Anadys Pharmaceuticals Inc Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one
AU2007249668B2 (en) 2006-04-11 2011-04-07 Novartis Ag HCV/HIV inhibitors and their uses
MX2008016518A (es) 2006-06-22 2009-01-19 Anadys Pharmaceuticals Inc Profarmacos de 5-amino-3-(3'-desoxi-beta-d-ribofuranosil)-tiazolo[ 4,5-d]pirimidin-2,7-dion.
WO2008011406A2 (en) 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
KR100880298B1 (ko) 2006-12-06 2009-01-28 애나디스 파마슈티칼스, 인코포레이티드 ３-β-Ｄ-리보푸라노실티아졸로[４,５-ｄ]피리미딘뉴클레오시드 및 이의 용도
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
PT2609923T (pt) 2010-03-31 2017-08-30 Gilead Pharmasset Llc Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
EA201390532A1 (ru) 2010-10-08 2013-09-30 Новартис Аг Композиции сульфамидых ингибиторов ns3, содержащие витамин е
JPWO2012102366A1 (ja) * 2011-01-28 2014-06-30 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
CA2960436C (en) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
CA2963717C (en) * 2014-12-08 2023-10-10 F. Hoffmann-La Roche Ag 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
CN107427514B (zh) 2015-03-16 2021-07-13 豪夫迈·罗氏有限公司 使用tlr7激动剂和hbv衣壳装配抑制剂的组合治疗
WO2016180691A1 (en) 2015-05-08 2016-11-17 F. Hoffmann-La Roche Ag Novel oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection
WO2016180743A1 (en) 2015-05-12 2016-11-17 F. Hoffmann-La Roche Ag Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
WO2017001307A1 (en) 2015-06-30 2017-01-05 F. Hoffmann-La Roche Ag Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
EP3568400B1 (en) 2017-01-06 2025-11-19 F. Hoffmann-La Roche AG Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives

Also Published As

Publication number Publication date
ATE173929T1 (de) 1998-12-15
EP0348446B1 (en) 1995-08-09
EP0348446A1 (en) 1990-01-03
DE3854297T2 (de) 1996-03-28
EP0636372B1 (en) 1998-12-02
US5041426A (en) 1991-08-20
CA1319931C (en) 1993-07-06
DE3856279D1 (de) 1999-01-14
EP0636372A1 (en) 1995-02-01
ES2010786A6 (es) 1989-12-01
WO1989005649A1 (en) 1989-06-29
AR246104A1 (es) 1994-03-30
DK406389A (da) 1989-10-04
ATE126060T1 (de) 1995-08-15
JPH03504122A (ja) 1991-09-12
DE3856279T2 (de) 1999-05-20
KR970002611B1 (en) 1997-03-06
JP2590248B2 (ja) 1997-03-12
KR900700106A (ko) 1990-08-11
EP0348446A4 (en) 1991-09-25
DE3854297D1 (de) 1995-09-14

Similar Documents

Publication Publication Date Title
DK406389A (da) Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK314789A (da) Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK404588D0 (da) Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK89090D0 (da) Farmaceutisk praeparat
DK705488A (da) Farmaceutisk praeparat
DK181586A (da) 2,5-diaryltetrahydrofuran, farmaceutisk praeparat indeholdendeen saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK655288D0 (da) Diarylstyrylquinolindisyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK287085A (da) Triazolobenzodiazepin og farmaceutisk praeparat indeholdende en saadanforbindelse
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
DK211689D0 (da) Fluoravermectin- og -milbemycinforbindelser og praeparat indeholdende en saadan forbindelse
DK166279C (da) 3,4-dihydro-2h-benzooebaapyranderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK537288A (da) Tetrahydrocarbazolester og farmaceutisk praeparat indeholdende en saadan forbindelse
DK224589A (da) Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK160991C (da) 5,14-dihydrobenzoe5,6aaisoindolooe2,1-baaisoquinolin-8,13-dionderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK23088D0 (da) Piperazinylpyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK191787A (da) Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK139388D0 (da) Farmaceutisk praeparat
FR2606559B1 (fr) Connecteur modulaire
DK276288D0 (da) Farmaceutisk praeparat
DK258086A (da) Substitueret hexahydroarylquinolin og farmaceutisk praeparat indeholdende en saadan forbindelse
DK686688A (da) 8,9-annelerede beta-carboliner, deres fremstilling og laegemidler indeholdende forbindelserne
DK513588A (da) Thieno(2,3-b)furan-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse
DK138888D0 (da) Farmaceutisk praeparat
DK330389A (da) Tetrahydropyranonforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse